The expression of thyroid hormone transporters in the human fetal cerebral cortex during early development and in N-Tera-2 neurodifferentiation
Non-technical summary
Thyroid hormones are important in brain development and they enter cells through thyroid hormone transporters at the cell membrane. Thyroid hormone transporters are thought to play an important role since gene defects in one of these transporters, MCT8, have been associated with severe mental retardation. This paper describes the expression of a range of thyroid hormone transporters in the human fetal brain during early pregnancy, which suggests that these transporters could regulate the supply of thyroid hormones into brain cells from very early in development. Surprisingly, the reduction of thyroid hormones and MCT8 expression do not affect the differentiation of an unspecialised cell to a specialised human nerve cell in the brain. Thyroid hormones and MCT8 are thus likely to affect other processes during human brain development.
To find out how thyroid hormones influence human fetal brain development requires further research.
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Introduction
The sensitivity of the human fetal central nervous system (CNS) to small reductions in thyroid hormone (TH) exposure has been suggested by studies associating maternal subclinical hypothyroidism and hypothyroxinaemia with long-term neurodevelopmental deficits in offspring (Haddow et al., 1999; Pop et al., 2003) . Current evidence suggests a direct effect of maternal THs upon fetal CNS development, particularly in the first half of pregnancy before the onset of endogenous fetal TH production (de Escobar et al., 2004) . In rodents, THs are known to affect the proliferation and differentiation of CNS cells (Jones et (Gilbert & Paczkowski, 2003) and dendritic branching (Heuer & Mason, 2003) . These effects are mostly mediated by nuclear TH receptors (TRs) , that bind the active TH ligand, triiodothyronine (T3), to influence THresponsive gene transcription.
Whilst circulating THs are the major determinants of TH supply, effective TH action requires the uptake of THs into cells and pre-receptor regulation of local T3 bioavailability by iodothyronine deiodinases. It is postulated that astrocytes express deiodinase type 2 (D2) that activates circulating thyroxine (T4) to T3 locally. Subsequently, T3 is transported into neurons, these cells being the ultimate target for TH action and shown to express TRs (Kilby et al., 2000) and deiodinase type 3 (D3), which inactivates any excess T3 (Tu et al., 1999) .
Specific transport mechanisms facilitate the cellular influx and efflux of THs (Hennemann et al., 2001 ). TH transporters are required for TH passage across the blood brain barrier (BBB) TH transport has also been demonstrated by monocarboxylate transporter 10 (MCT10), several organic anion transporting polypeptides (OATP) and System-L amino acid transporters (LAT).
They have slightly different affinities for THs and transport other compounds (Table 1) . Their expressions have been described in human adult brains and rodent brains but there have been few studies of the early human fetal brain.
It has been hypothesised that the regulation of cellular TH entry by TH transporters is critical to timely TH action during human fetal brain development, particularly neurodevelopment. We have, therefore, investigated changes in the expression of TH transporters within the human fetal cerebral cortex during the first half of gestation and during the neurodifferentiation of N-Tera-2 (NT2) cells, a human pluripotent embryonal cell line with characteristics of CNS precursors, which can be terminally differentiated into functional neurons (Andrews et al., 1984) . We assessed if compensatory changes in TH transporter activity occurred with T3-depletion and, specifically, if MCT8 expression is important in NT2 neurodifferentiation. 
Materials and Methods

Ethical Approval
All tissue samples were obtained with the approval of the East Birmingham and South Birmingham Local Research and Ethics Committees, with written parental consent, and within the terms of the New Human Tissue Act, UK (2004) and the Declaration of Helsinki.
Human Tissues
Sixty-five human fetuses of gestational ages between 7 and 20 post-menstrual weeks (weeks) were examined after surgical termination of pregnancy and cerebral cortices biopsied as previously described (Chan et al., 2002; Kilby et al., 2000) . In brief, the fetal cortex was identified at operation and a biopsy taken as histological evaluation of paraffin embedded sections, and further samples snap frozen immediately in liquid nitrogen. Fetuses were grouped thus: early 1 st trimester 7-9 weeks (n=11), late 1 st trimester 10-12 weeks (n=25), early 2 nd trimester 13-16 weeks (n=20) and mid 2 nd trimester 17-20 weeks (n=9). In addition, samples of normal adult cerebral cortex (n=10) taken at post-mortem and donated to the UK National Brain Bank were obtained (The Institute for Neurological Diseases, Queen's Square, London, UK). All samples were snapfrozen in liquid nitrogen and stored at -80°C until required for RNA and protein evaluation.
RNA extraction, reverse transcription and real time quantitative TaqMan® PCR
Total RNA was extracted from 100mg frozen tissue after homogenisation, using TRIagent (Sigma, Poole, UK), as described previously (Chan et al., 2002) . RNA (1g) was reverse transcribed using avian myeloblastosis virus (AMV) reverse transcriptase (Promega Corp.,
Madison, WI, USA) in a total reaction volume of 20l, with random hexamer primers according to manufacturer's instructions then diluted 1:2 with RNAse free water.
RT-PCR was carried out in 25l reactions on 96-well plates in a reaction buffer containing 1X
TaqMan® Universal PCR Master Mix, 150 nmol TaqMan® probe and 900 nmol primers using the ABI PRISM 7500 Sequence Detection System, as described previously (Chan et al., 2002) .
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) at Universitaet Zuerich on April 6, 2011 jp.physoc.org Downloaded from J Physiol ( 126   127   128   129   130   131   132   133   134   135   136   137   138   139   140   141   142   143   144   145   146   147   148   149 Primers and FAM-labelled probe sets for all genes were as previously validated and described (Chan et al., 2006; Loubiere et al., 2010 ) except for OATP3A1 variants 1 and 2, which were newly designed with Primer Express v3.0 (Applied Biosystems) (Table 2 ) and validated alongside control RT reactions without AMV. To provide an internal reference for RT efficacy, 18S ribosomal RNA and cyclophilin VIC-labelled-probes and primers (Applied Biosystems, Warrington, UK) were selected for normalisation based upon preliminary tests using the TaqMan® Human Endogenous Control Array plate (Applied Biosystems, Warrington, UK) and model-based calculations as previously described (Andersen et al., 2004) . All reactions were performed single-plexed in duplicate. Relative quantifications of each gene were determined, as previously described , and normalised to the geometric means of the two control genes. The mean mRNA expression for adult samples was assigned the arbitrary value of 1. The relative mRNA expression for each sample compared to the mean for adults was calculated and used to perform statistical analysis.
Immunohistochemistry
Formalin-fixed paraffin-embedded sections (5μm) of forebrain (telencephalon) from three surgically terminated pregnancies between 8 and 11 weeks gestation were obtained from the London Neurogenerative Disease Brain Bank (Institute of Psychiatry, King's College London).
Sections were immunostained for MCT8 or MCT10 using an avidin-biotin peroxidase technique (Vectastain Elite, Vector Laboratories, Peterborough, UK) as we have previously described (Kilby et al., 2000; Boelaert et al., 2003) . Briefly, after de-waxing with Histoclear and serial rehydration with ethanol, sections were incubated in 10mM sodium citrate buffer (pH 6.0) at 95ºC for 5 minutes for antigen retrieval. After washing in 50mM Tris/0.15M saline (pH 7.5; TBS), the sections were blocked with 10% normal goat serum (Sigma-Aldrich, UK) in diluting buffer (TBS, 0.3%Tween 20, 2%BSA) for 20 minutes before incubation overnight at 4ºC with the primary antibody MCT8 (1:800) or MCT10 (1:800). The manufacture and specificity of the MCT8 (4790) 151   152   153   154   155   156   157   158   159   160   161   162   163   164   165   166   167   168   169   170   171   172 173 , MCT10 (2198) antibodies [ Figure 1C and 1D] have been previously described. Specificity of immunostaining was further confirmed using adjacent sections as negative controls treated with the primary antibody pre-absorbed by an excess of blocking peptide. With TBS-Tween washes between each step, the sections were incubated with biotinylated goat anti-rabbit secondary antibody (1:200; Vector Laboratories, UK) for 30 minutes, followed by 5% hydrogen peroxide in TBS (5 minutes), then avidin-biotinperoxidase complex application (30 minutes) and developed by incubation in 3,3'-diaminobenzidine (Vector Laboratories, UK) for 5-15 minutes. Sections were rinsed in distilled water and mounted in Vectashield mounting media (Vector Laboratories, UK).
Neurodifferentiation of NT2 cells
NT2 cells (European Collection of Cell Cultures, Salisbury, UK) were maintained in DMEM:Hams F12 (1:1) Dulbecco's growth medium supplemented with 10% (v/v) fetal bovine serum (FBS), 2mM L-glutamine and 100U/ml of penicillin/streptomycin (Invitrogen Ltd., UK) as previously described (Andrews et al., 1984) . Cells were passaged and split 1:4 twice weekly, and cultured at 37 o C and 5% CO 2 . Differentiation of NT2 precursor cells to terminally differentiated neurons with retinoic acid (RA) treatment was conducted based on methods previously described (Pleasure et al., 1992; Chan et al., 2003) . Charcoal-stripped FBS (First Link Ltd., UK), which is virtually devoid of THs, was used to create a T3-depleted environment. Since NT2 cells were unable to tolerate 5 weeks in culture with media supplemented with charcoalstripped FBS alone, differentiation experiments were performed in media containing 2% of normal FBS with 8% of charcoal-stripped FBS (combination media) with the addition of 10nM T3 (T3-replete) and without T3 (T3-depleted) along with 10µM RA (Sigma-Aldrich, UK). We had previously shown that the dose of 10nM T3 was optimal in the induction of T3-responsive gene expression in NT2 cells (Chan et al., 2003) .
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Pou5F1, nestin, neurofilament-light, were designed and validated (Table 2 ). All reactions were performed single-plexed along side VIC-labelled-probe and primers for 18S ribosomal RNA (Applied Biosystems, Warrington, UK) as an internal reference. Relative mRNA expression was calculated as above within each experiment with the mean expression at time 0 assigned the arbitrary value of 1.
Western blotting and Flow cytometry
Protein was extracted on Days 0, 3, 7 and 14 (n=4 experiments) using RIPA buffer (150 mM sodium chloride, 1% Triton X-100, 1mM EDTA, 0.25% sodium deoxycholate and 50 mM Tris, pH7.4) with protease inhibitors then quantified (Bradford assay). Western immunoblotting was performed as we have previously described (Boelaert et al., 2003; Loubiere et al., 2010) . Protein (30µg) was denatured (30 min at 37°C or 95°C ) in Laemmli buffer containing DTT and 1% SDS, then separated by electrophoresis in 8% or 10% SDS-PAGE gel and blotted onto nitrocellulose membranes. Blots were incubated in 5% non-fat milk in 20mM Tris/137mM NaCl, Tween 0.025% (TBS-Tween; pH 7.6) then probed with primary antibody overnight. The manufacture and specificity of the OATP antibodies have also been previously described (Huber et al., 2007; Gao et al., 2005) . Rabbit polyclonal primary antibodies were used at 1:500 for MCT8, 
Morphological assessments of differentiated neurons
To isolate fully differentiated neurons, cells were RA treated three times a week for 5 weeks then Repressing MCT8 expression using siRNA MCT8 knock-down experiments were carried out using predesigned MCT8-specific siRNAs (ID#117397, Ambion Inc., Huntingdon, UK) as previously described (James et al., 2009) quantified by TaqMan® RT-PCR as described above. We had previously confirmed that MCT8
repression by MCT8-specific siRNAs resulted in a significant reduction in T3 uptake by 19% at 72 hours post-transfection compared with 'scrambled' controls (James et al., 2009 ).
Statistical Analyses
Data were analysed using Sigma Stat software version 3.1 (SPSS Science Software UK Ltd). For the ontogeny data, the Kruskal-Wallis ANOVA was used for between group comparisons with Dunn's post-hoc multiple comparisons testing to isolate groups that differed from others. 
Expression of TH transporters in the human fetal cerebral cortex
Monocarboxylate Transporters (MCTs)
The levels of mRNA encoding both MCT8 and MCT10 did not demonstrate any statistically significant differences in the fetal cerebral cortex across gestation (7 to 20 weeks) and when compared with adult ( Figure 1A, 1B) .
The presence of both MCT8 and MCT10 protein from early gestation was confirmed by immunohistochemistry ( Figures 1E-F 
System L-type amino acid transporters (LATs and CD98)
Messenger RNA encoding LAT1 did not show any statistically significant differences in expression in the fetal cerebral cortex between 7 to 20 weeks and when compared with adult 
Expression of TH transporters and response to T3 during NT2 neurodifferentiation
With the localisation of MCT8 and MCT10 in CNS precursor cells and neurons being the postulated ultimate target cell of T3 action in the brain during development, we went on to investigate human neurodifferentiation in vitro using human CNS precursor NT2 cells, which express the TR isoforms, 1, 2 and 1, and are T3-responsive. They demonstrate increased mRNA expression of the thyroid hormone responsive gene, TR1 (Chan et al., 2003) , and increased cell proliferation in response to T3 treatment (James et al., 2009 ).
T3 does not affect NT2 neurodifferentiation
The changes in mRNA expression of three neurodifferentiation markers, Pou5F1, nestin and neurofilament, across 21 days of RA treatment ( Figure 4A -C) were consistent with that previously described in NT2 cells (Przyborski et al., 2003) and were similar for NT2 cells 
TH transporter expression with NT2 neurodifferentiation
We then investigated if the lack of effect of T3-depletion upon NT2 neurodifferentiation was due 
T3 uptake by NT2 cells during neurodifferentiation
To assess the combined effects of the TH transporters upon net T3 uptake over the course of RA induced neurodifferentiation, comparisons of T3 uptake were made from data obtained after 10 minutes of incubation in [ 125 I]T3. There was a significant decline of 52-55% in T3 uptake between Day 0 compared with Days 7 and 14 of RA treatment (P<0.05 for both; Figure 5J ).
However, no differences in T3 uptake were observed between cells cultured in T3-depleted media compared with T3 replete media at 2, 10 and 30 minutes after incubation in [ 125 I]T3 (only data at 10 minutes are shown in Figure 5J ).
MCT8 repression does not affect NT2 neurodifferentiation
Given the association of MCT8 mutations with severe neurological impairment, that MCT8
represses NT2 proliferation independently of T3 (James et al., 2009) , that early overexpression of The presence of MCT8, OATP1C1, OATP1A2, OATP4A1, LAT1 and LAT2 is consistent with previous reports based on studies of the human fetal brain at later gestations (Table 1) .
Descriptions of the expression of OATP3A1 (variants 1 and 2) and MCT10, and the localisation MCT8 and MCT10 within the human fetal cerebral cortex in the 1st trimester of pregnancy are novel. Even though NT2 cells express multiple TH transporters and demonstrate T3 uptake, T3
and specifically MCT8 are not critical for NT2 neurodifferentiation.
Minor aberrations in maternal thyroid function occurring before the onset of endogenous fetal TH production in the midtrimester of human pregnancy are associated with long-term neurodevelopmental sequelae in offspring (Haddow et which have been localised to human fetal microglia (Wirth et al., 2009 ) and in rat neurons and astrocytes (Heckel et al., 2003) . The contrasting mRNA expression patterns of the splice variants of OATP3A1 may reflect their differential role during development and is suggested by their differential distribution in the adult cerebral cortex: OATP3A1v1 in grey matter astrocytes and OATP3A1v2 in grey and white matter neurons (Huber et al., 2007) .
The variation in mRNA abundance between subjects, even within the same gestational age group, is partly attributable to slightly different brain areas being sampled. However, the strength of our study is the large numbers of fetal cortices being analysed, which could partially compensate for these variations and allow ontogenic patterns to emerge. Even for adult samples, which were biopsied from a similar area of the cortex, large variations in mRNA expression of some transporters are still present and this may be due to genuine biological variation.
The expression of multiple transporters in the fetal brain may suggest redundancy in TH-uptake mechanisms but the severe neurological phenotype in individuals with an isolated non-functional MCT8 mutation implies the contrary argument. It has been postulated that very low OATP1C1 expression in the BBB and the lack of LAT2 expression in developing neurons cannot compensate for the lack of MCT8 function in humans unlike in rodents where there is higher Oatp14 (rodent equivalent of OATP1C1) expression at the BBB (Roberts et al., 2008) In NT2 cells trends in TH transporter mRNA expression were not always reflected by trends in protein expression. Post-transcriptional modulation is likely to be involved and such discrepancies have been reported in plasma membrane transporters such as MCT8 in human placenta and Oats in rat kidney (Zlender et al., 2009 ), although mechanisms remain unknown.
The lack of difference in the rate of neurodifferentiation and neuronal morphology between the T3-depleted and T3-replete cells suggests that NT2 neurodifferentiation is not a T3-responsive process. Our findings challenge the prevailing notion that THs are critical to neurodifferentiation, conclusions which have been based upon research in rats and mice, predominantly on cerebellar neurons (Horn & Heuer, 2010) . One study of non-CNS derived human fetal olfactory neuroepithelium did, however, demonstrate increased neurofilament-M expression assessed by immunocytochemistry in response to T3 treatment (Benvenuti et al., 2008) which is in contrast to NT2 cells. Apart from the fact that the Mct8 knockout mice show hardly any neurological deficits unlike humans, the mouse and rat cerebral cortex also differs from humans in that they demonstrate deiodinase type 1 (D1) activity (Visser et al., 1982) , which can activate circulating T4 into T3, whilst human brains show no D1 activity (Chan et al., 2002) . Thus, findings of TH action and metabolism in rodent CNS cannot readily be extrapolated to the human situation.
Since MCT8 also has T3-independent anti-proliferative effects (James et al., 2009 ), we specifically assessed the effects of MCT8 repression in NT2 neurodifferentiation. The absence of any changes in neurodifferentiation marker expression, despite significant MCT8 repression, suggests that MCT8 does not play a critical role in NT2 neurodifferentiation either. Mct8 has been shown to accelerate the neurodifferentiation of murine ES cells (Sugiura et al., 2007) and RA has been reported to stimulate Mct8 expression in murine F9 embryonal carcinoma cells (Kogai et al., 2010) but NT2 cells display neither of these phenomena, which may be indicative of yet more differences in neurodevelopment between mice and humans. 
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